Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 1.00 |
| ▸ | ADH1B | P00325 | 4/20 | 1.00 |
| ▸ | ADH1A | P07327 | 4/20 | 1.00 |
| ▸ | ADH7 | P40394 | 4/20 | 1.00 |
| ▸ | ADH1C | P00326 | 3/20 | 1.00 |
| ▸ | ADH4 | P08319 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.45 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL303653 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL145544 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL9660807 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL9661679 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL302735 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL9661848 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL58363 | 1.00 | — | — | |
| SCHEMBL9658779 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL4879688 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL305123 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506175-B1 | N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2009-04-01 | — | — | EP | claimed |
| US-7196110-B2 | N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders | JANSSEN PHAMACEUTICA N.V. (BE) | 2007-03-27 | — | — | US | claimed |
| CN-1668601-A | N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2005-09-14 | — | — | CN | claimed |
| US-20040082639-A1 | N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders | JANSSEN PHARMACEUTICA, N.V. (BE) | 2004-04-29 | — | — | US | claimed |
| US-20240033189-A1 | METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION | BASF SE (DE) | 2024-02-01 | — | — | US | disclosed |
| US-20230240432-A1 | METHOD FOR PRODUCING PERSONALIZED COSMETICS | BASF SE (DE) | 2023-08-03 | — | — | US | disclosed |
| WO-2023117874-A1 | ENVIRONMENTAL ATTRIBUTES FOR COSMETIC INGREDIENTS | BASF SE (DE) | 2023-06-29 | — | — | WO | disclosed |
| EP-2852581-B1 | NOVEL 1,3-BENZOXAZOL-2(3H)-ONES AND THEIR USE AS MEDICAMENTS AND COSMETICS | WOLFF AUGUST GMBH & CO KG ARZNEIMITTEL DR (DE) | 2016-05-04 | — | — | EP | disclosed |
| US-9255070-B2 | Method of deuteration using mixed catalyst | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-8093422-B2 | Method for deuteration of an aromatic ring | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-01-10 | — | — | US | disclosed |
| US-7795440-B2 | N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders | JANSSEN PHARMACEUTICA NV (BE) | 2010-09-14 | — | — | US | disclosed |
| US-7517990-B2 | Method for deuteration of a heterocyclic ring | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-14 | — | — | US | disclosed |
| US-4264722-A | A COLORLESS CYAN-COLOR-FORMING COUPLER COMPRISING 4-OXY-DERIVATIVES OF 1-HYDROXY-2-SEC-AMIDO-NAPHTHALENE OR BENZENE | FUJI PHOTO FILM CO., LTD. (JP) | 1981-04-28 | — | — | US | disclosed |
| US-4254212-A | ALKOXY SUBSTITUTED SULFONYL | FUJI PHOTO FILM CO., LTD. (JP) | 1981-03-03 | — | — | US | disclosed |
| EP-0024033-A1 | Photographic colour couplers and light-sensitive material containing them | FUJI PHOTO FILM CO., LTD. (JP) | 1981-02-18 | — | — | EP | disclosed |
| US-4228233-A | CYAN DYE FORMING, COLORLESS COUPLER | FUJI PHOTO FILM CO., LTD. (JP) | 1980-10-14 | — | — | US | disclosed |
| US-4217410-A | CYAN DYE COUPLER, PHOSPHATE SOLVENTS | FUJI PHOTO FILM CO., LTD. (JP) | 1980-08-12 | — | — | US | disclosed |
| US-4083721-A | AROMATIC PRIMARY AMINE DEVELOPER | FUJI PHOTO FILM CO., LTD. (JA) | 1978-04-11 | — | — | US | disclosed |
| US-4072525-A | COLOR PHOTOGRAPHY | FUJI PHOTO FILM CO., LTD. (JA) | 1978-02-07 | — | — | US | disclosed |
| US-4032345-A | SILVER HALIDE MATERIALS CONTAINING PHOTOGRAPHIC COLOR COUPLERS WITH ISOTHIOCYANATO GROUPS | FUJI PHOTO FILM CO., LTD. (JA) | 1977-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240432-A1 | METHOD FOR PRODUCING PERSONALIZED COSMETICS | CUTA, TYR, SUCLG1 | EPHX1 318/4885ADH1B 20/4885ADH1A 200/4885 |
| US-20240033189-A1 | METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION | CUTA, NISCH, TYR | EPHX1 477/4885ADH1B 63/4885ADH1A 514/4885 |
| US-20040082639-A1 | N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders | PDGFRA, PDGFRB, PDGFA | EPHX1 3133/4885ADH1B 3078/4885ADH1A 3719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.